Stomach Cancer Clinical Trials

A listing of Stomach Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Tucson Arizona 85715

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

California

Duarte California 91010-0269

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

La Jolla California 92037-0845

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Stomach Cancer, Gastric (Stomach) Cancer, Neoplasm of Cardioesophageal Junction or Gastrointestinal Stromal Tumor (GIST)

Connecticut

Plainville Connecticut

A clinical research study for the treatment of Gastric Adenocarcinoma

Indiana

Goshen Indiana

A clinical research study for the treatment of Gastric Adenocarcinoma

Massachusetts

Worcester Massachusetts 01655

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

New York

Bronx New York 10461

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

New York New York 10021

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Oklahoma

Tulsa Oklahoma 74146

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Temple Texas 76508

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Washington

MultiCare Health System
Tacoma Washington 98405

Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach

View More ▼

Olympia Washington 98502

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Argentina

Buenos Aires 1025

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Rosario 2000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Viedma 8500

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Australia

Adelaide 5000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Kingswood 2747

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Melbourne 3144

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Nedlands 6009

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Woolloongabba 4102

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Belgium

Brussels 1000

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Kortrijk 8500

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Namur 5000

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Canada

Calgary T2N 4N2

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Edmonton T6G 1Z2

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Oshawa L1G 2B9

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Czech Republic

Brno 656 53

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Novy Jicin 741 01

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Olomouc 775 20

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Praha 150 06

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

France

Brest 29609

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Creteil 94010

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Lyon 69437

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Paris 75013

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Germany

Berlin 13125

A clinical trial to evaluate treatments for patients with Colo-rectal Cancer, Stomach Cancer or Melanoma

Giessen 35392

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Hamburg 20246

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Munich 81737

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Ravensburg 88212

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Greece

Athens 18537

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Haidari 12462

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Heraklion 71110

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Patras 26504

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Thessaloniki 56429

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Hungary

Budapest 1125

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Kaposvar 7400

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Szolnok 5000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma